Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGWP.L Regulatory News (GWP)

  • There is currently no data for GWP

Director Shareholding

2 Mar 2005 14:05

GW Pharmaceuticals PLC02 March 2005 For Immediate Release 2 March 2005 GW Pharmaceuticals plc ('the Company') Share Options The following Directors of the Company have been granted share options on 2March 2005, as detailed below: Director No. of shares over which Total no. of shares over options granted which options held Dr Geoffrey 302,344 1,083,924Guy Justin 239,063 1,491,167Gover David Kirk 217,969 1,773,747 Dr Brian 98,438 678,230Whittle David Mace 45,000 251,620 Hans 45,000 119,120Schram Peter 45,000 179,120Mountford The options to acquire ordinary shares of 0.1p in the Company have been grantedat an exercise price of 128p and are exercisable from 2 March 2008 to 2 March2015 and have been granted as part of the Directors' remuneration review carriedout at the end of 2004. For further information please contact Jonathan Laughton, Company Secretary &Financial Controller, GW Pharmaceuticals plc on +44 (0) 1980 557 000. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
22nd Jun 20162:22 pmRNSHolding(s) in Company
21st Jun 201612:00 pmRNSEpidiolex Development Program in Infantile Spasms
17th Jun 20165:05 pmRNSHolding(s) in Company
8th Jun 20164:54 pmRNSHolding(s) in Company
31st May 20161:25 pmRNSTotal Voting Rights
31st May 201612:00 pmRNSPresents at Goldman Sachs and Jefferies Conference
16th May 201612:00 pmRNSGWP presenting at UBS Global Healthcare Conference
13th May 20163:50 pmRNSDirector/PDMR Shareholding
11th May 20165:19 pmRNSDirector/PDMR Shareholding
5th May 201612:00 pmRNSHalf-year Report
4th May 201612:00 pmRNSPresenting at BoAML 2016 Healthcare Conference
29th Apr 20161:37 pmRNSTotal Voting Rights
28th Apr 201612:00 pmRNSNotice of Results
21st Apr 201612:00 pmRNSOrphan Drug Designation for Cannabidiol in TSC
11th Apr 201612:00 pmRNSInitiates Ph 3 Study in Tuberous Sclerosis Complex
1st Apr 20163:24 pmRNSDirector/PDMR Shareholding
23rd Mar 20165:07 pmRNSResult of AGM
18th Mar 20163:34 pmRNSBlock Listing Application
14th Mar 201611:00 amRNSEpidiolex Positive Phase 3 Pivotal Study Results
29th Feb 20169:26 amRNSTotal Voting Rights
22nd Feb 20166:16 pmRNSNotice of AGM
17th Feb 201610:37 amRNSBlocklisting Interim Review
15th Feb 20162:39 pmRNSDirector/PDMR Shareholding
10th Feb 201612:00 pmRNS1st Quarter Results
4th Feb 20163:45 pmRNSPresenting at Leerink Global Healthcare Conference
2nd Feb 20163:07 pmRNSNotice of Results
29th Jan 201611:42 amRNSTotal Issued Share Capital
29th Jan 20169:29 amRNSHolding(s) in Company
28th Jan 20168:47 amRNSHolding(s) in Company
25th Jan 20168:33 amRNSHolding(s) in Company
6th Jan 201612:01 pmRNSPublication of UK Annual Report and Accounts
31st Dec 201510:42 amRNSTOTAL ISSUED SHARE CAPITAL
29th Dec 20152:26 pmRNSDirector/PDMR Shareholding
24th Dec 201512:00 pmRNSLancet Neurology Publishes Epidiolex Data
22nd Dec 20155:14 pmRNSDirector/PDMR Shareholding
21st Dec 20156:22 pmRNSDirector/PDMR Shareholding
16th Dec 20154:16 pmRNSDirector/PDMR Shareholding
16th Dec 20159:27 amRNSDirector/PDMR Shareholding
8th Dec 20157:00 amRNSFinal Results
7th Dec 20156:00 pmRNSNew Physician Reports of Epidiolex Treatment
30th Nov 20151:00 pmRNSDate and Time Change for Q4 and FY 2015 Results
30th Nov 20159:38 amRNSTotal Voting Rights
25th Nov 20152:00 pmRNSEpidiolex data to be presented at AES Meeting
24th Nov 20156:00 pmRNSNotice of Results
24th Nov 20156:00 pmRNSPresenting at Piper Jaffray Healthcare Conference
2nd Nov 201510:09 amRNSTotal Voting Rights
27th Oct 201511:05 amRNSAgreement with NSW to Study Epidiolex and CBDV
27th Oct 201511:00 amRNSResults from Sativex Phase 3 Cancer Pain Trials
15th Sep 20152:00 pmRNSPositive Proof of Concept Data in Schizophrenia
10th Sep 20152:00 pmRNSPresenting at Two Upcoming Investor Conferences

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.